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Dear Colleagues,
So expected summer holidays are now inevitably 
coming to an end. Returning to work means new chal-
lenges and permanent searching for optimal forms 
of diagnostics and treatment of diabetes aimed first 
of all at the reduction of vascular complications of 
diabetes and, as a consequence, improved quality of 
life of the patients. Diabetic patients are hospitalized 
3-fold more frequently compared with people with-
out carbohydrate metabolism disturbances and the 
risk of mortality is 3–4-fold higher than in remaining 
population. Chronic hyperglycaemia seems to be a key 
factor leading to the development and progression 
of vascular complications of diabetes, besides the 
impact of genetic predisposition and broadly defined 
environmental factors such as poor diet, low physical 
activity and obesity. In type 1 diabetes hyperglycaemia 
results from absolute insulin deficiency, whereas in 
type 2 diabetes it is a consequence of a number of 
processes leading to decreased peripheral tissue sen-
sitivity to insulin (mainly muscles and adipose tissue) 
i.e. insulin resistance and/or dysfunction of pancreatic 
beta cells causing impaired insulin secretion. Avail-
able studies show close association between severity 
and duration of blood glucose elevation and the risk 
of chronic vascular complications of diabetes. These 
associations have been proven both in type 1 and 
type 2 diabetes. Despite recent advances in medicine, 
introduction of new hypoglycaemic drugs and the 
fact that more than 3.500 years have passed since the 
earliest known record of diabetes in Egyptian papyrus 
dated back to around 1550 B.C., the development of 
late complications of diabetes, which significantly de-
teriorate patients’ quality of life, still remains the most 
important problem in contemporary diabetology and 
diabetes itself remains an incurable disease. 
A new issue of Clinical Diabetology discusses these 
topics, both the aspect of vascular complications and 
available diagnostics and treatment. I hope that this 
issue of our Journal will support our readers in everyday 
practice and help them in making clinical decisions. It 
should be remembered that medicine still remains an 
art that frequently does not know easy ways and com-
pletely anticipated solutions and that the management 
of diabetes, like the treatment of other human diseases, 
should be related to maximum benefits for patients and 
lead to increase in their quality of life.
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